UBS raised the firm’s price target on PTC Therapeutics (PTCT) to $71 from $47 and keeps a Buy rating on the shares. PTC Therapeutics on Monday announced a global licensing and collaboration agreement ...

Citi raised the firm’s price target on PTC Therapeutics (PTCT) to $32 from $26 and keeps a Sell rating on the shares. The firm updated the company’s model to reflect the Novartis collaboration, which ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Novartis, Gilead, Roche and Takeda commit to new partners in a spate of mid-sized collaborations this week. Meanwhile, ...

Speaking at the 11th Annual Clinical Trials in Oncology conference in Munich, a panel of experts urged trial designers to be ...

South Korean Leader’s Fate Is in Doubt as Lawmakers Move to Impeach Him The effort to remove President Yoon Suk Yeol reflected fury over his declaration of martial law. He lifted the order ...

The effort to remove President Yoon Suk Yeol reflected fury over his declaration of martial law. He lifted the order within hours after it incited protests. Members of South Korea’s opposition ...

Like many other organizations in Bowling Green, United Way of Southern Kentucky’s Emerging Leader Society celebrated the Thanksgiving ... Restaurant inspections for Nov. 6-13 according to the ...

U.S. Marshals are on the hunt for a man they say murdered a 29-year-old woman and then buried her body in a shallow grave, according to authorities. The FBI director nominee Kash Patel was hit ...

Kansas City Chiefs receiver Xavier Worthy is beginning to catch the attention of the opposing defense with his play over the last three weeks.

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...

Get dialed in every Tuesday & Friday with quick updates on the world of crypto ...